Brian Elsbernd Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

Brian Elsbernd is Chief Compliance/Legal Officer of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 176,524 shares of CPRX, which is worth approximately $3.82 Million. The most recent transaction as insider was on Dec 09, 2024, when has been sold 1,720 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 177K

41.86% 3M change

27.85% 12M change

Total Value Held $3.82 Million

Brian Elsbernd Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 09 2024	SELL Payment of exercise price or tax liability	-	1,720 Reduced 0.96%	176,524 Common Stock, par valu...
Dec 09 2024	BUY Exercise of conversion of derivative security	-	7,067 Added 3.81%	178,244 Common Stock, par valu...
Nov 26 2024	SELL Open market or private sale	$286,594 $21.62 p/Share	13,256 Reduced 7.19%	171,177 Common Stock, par valu...
Nov 26 2024	BUY Exercise of conversion of derivative security	$240,600 $4.01 p/Share	60,000 Added 25.52%	175,133 Common Stock, par valu...
Mar 27 2024	SELL Open market or private sale	$411,000 $16.44 p/Share	25,000 Reduced 16.73%	124,433 Common Stock, par valu...
Feb 15 2024	SELL Payment of exercise price or tax liability	-	2,353 Reduced 1.55%	149,433 Common Stock, par valu...
Feb 15 2024	BUY Exercise of conversion of derivative security	-	9,667 Added 5.99%	151,786 Common Stock, par valu...
Dec 27 2023	SELL Payment of exercise price or tax liability	-	2,623 Reduced 1.81%	142,119 Common Stock, par valu...
Dec 27 2023	BUY Exercise of conversion of derivative security	-	6,666 Added 4.4%	144,742 Common Stock, par valu...
Mar 20 2023	SELL Open market or private sale	$803,500 $16.07 p/Share	50,000 Reduced 26.58%	138,076 Common Stock, par valu...
Mar 20 2023	BUY Exercise of conversion of derivative security	$56,499 $1.13 p/Share	50,000 Added 21.0%	188,076 Common Stock, par valu...
Feb 15 2023	SELL Payment of exercise price or tax liability	-	2,353 Reduced 1.68%	138,076 Common Stock, par valu...
Feb 15 2023	BUY Exercise of conversion of derivative security	-	9,666 Added 6.44%	140,429 Common Stock, par valu...
Dec 06 2022	BUY Exercise of conversion of derivative security	-	14,667 Added 10.09%	130,763 Common Stock, par valu...
Nov 14 2022	BUY Exercise of conversion of derivative security	$138,600 $1.32 p/Share	105,000 Added 47.49%	116,096 Common Stock, par valu...
Nov 11 2022	SELL Open market or private sale	$238,029 $16.23 p/Share	14,666 Reduced 56.93%	11,096 Common Stock, par valu...
Dec 03 2021	SELL Payment of exercise price or tax liability	-	3,571 Reduced 12.17%	25,762 Common Stock, par valu...
Dec 03 2021	BUY Exercise of conversion of derivative security	-	14,667 Added 33.33%	29,333 Common Stock, par valu...
Dec 22 2020	BUY Exercise of conversion of derivative security	-	14,666 Added 50.0%	14,666 Common Stock, par valu...

Brian Elsbernd

Chief Compliance/Legal Officer

Coral Gables, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX

Account